Open-Label Safety Study of AXS-05 in Subjects With Alzheimer's Disease Agitation
Status:
Enrolling by invitation
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, open-label trial to evaluate the long-term safety and efficacy of
AXS-05 in subjects with agitation associated with Alzheimer's disease (AD).